FDA Adverse Event Injury Summary report: N

UNKNOWN ENDO GIA SULU

MDR report key: 14681581 · Received June 13, 2022

Report

Report Number
1219930-2022-02212
Event Type
Injury
Date Received
June 13, 2022
Date of Event
November 6, 2020
Report Date
June 13, 2022
Manufacturer
COVIDIEN LP LLC NORTH HAVEN
Product Code
GDW
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

LITERATURE: TITLE: REINFORCED VERSUS STANDARD STAPLER TRANSECTION ON POSTOPERATIVE PANCREATIC FISTULA IN DISTAL PANCREATECTOMY: MULTICENTRE RANDOMIZED CLINICAL TRIAL SOURCE: BJS, 2021, 108, 265¿270 DOI: 10.1093/BJS/ZNAA113 ADVANCE ACCESS PUBLICATION DATE: 20 JANUARY 2021. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

ACCORDING TO THE LITERATURE, A RETROSPECTIVE STUDY ANALYZED OUTCOMES OF PATIENTS WHO UNDERWENT DISTAL PANCREATECTOMY TO EVALUATE THE EFFECT OF STAPLE REINFORCEMENT BETWEEN MAY 2014 AND FEBRUARY 2016. THE PANCREATIC REMNANT WAS CLOSED USING AN ENDOSCOPIC STAPLER OR A COMPETITOR DEVICE. IN ONE GROUP, A REINFORCEMENT FROM ANOTHER MANUFACTURER WAS USED WITH THE STAPLER (56 PATIENTS), IN THE OTHER GROUP THE REINFORCEMENT WAS NOT USED (50 PATIENTS). COMPLICATIONS INCLUDED BLEEDING, ABDOMINAL COLLECTION AND POSTOPERATIVE PANCREATIC FISTULAS. RADIOLOGICAL AND SURGICAL REINTERVENTIONS AND READMISSIONS WERE REPORTED. IT WAS MENTIONED THAT THE PANCREATIC FISTULAS WERE A PROCEDURAL RISK AND THE STUDY RESULTS CONFIRM THAT POSTOPERATIVE PANCREATIC FISTULA CANNOT BE PREVENTED OR REDUCED USING DIFFERENT TECHNIQUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1687728 UNKNOWN ENDO GIA SULU STAPLE, IMPLANTABLE GDW COVIDIEN LP LLC NORTH HAVEN UNKNOWN ENDO GIA SULU

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention| H